Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Pharma

In our rearview mirror is a ten-year stretch of experimentation. What looms ahead is the rewriting of healthcare's rules.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

Whoever's closest to the consumer will be the gatekeeper of the industry.

Principal, Oliver Wyman
Engagement Manager, Oliver Wyman
Senior Consultant, Oliver Wyman

Three percent of consumers drive 70 percent of pharmacy spend. Pharmacy is ripe for change.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Senior Advisor, Oliver Wyman

It's time to get comfortable with being uncomfortable.

Partner, Health & Life Sciences, Oliver Wyman

How measurement and monitoring will wake physicians up to their dangerous, unnecessary, (and unintentional) prescribing habits.

Global Head, Health Services, Oliver Wyman

Insights in your inbox

Subscribe

There's big buzz around consumer behavior driving outcomes. But clinical data doesn't yet align with behavioral data.

Principal, Health & Life Sciences, Oliver Wyman

Q&A with the Academy of Nutrition and Dietetics on malnutrition's greatest challenges and opportunities

What if your doctor handed out grocery lists, not a grocery list of pills to take?

Principal, Oliver Wyman
Chief Science Officer, Academy of Nutrition and Dietetics

Pharma companies and providers in search of better solutions must look to the patient experience for answers.

Partner, Digital & Analytics, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

A closer look at how fast change may happen, who could win (and lose), and how the next decade may unfold for incumbents and new market entrants.

Partner, Health & Life Sciences, Oliver Wyman
Senior Knowledge Expert, Health & Life Sciences, Oliver Wyman

2018 was a big year for industry news. Here's what might happen next in artificial intelligence, the 2020 presidential election, pharma, and more.

Partner, Health & Life Sciences, Oliver Wyman
Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman

Insights in your inbox

Subscribe